1. Introduction
===============

Breast cancer (BC) is the most common cancer in females worldwide,^\[[@R1],[@R2]\]^ and is the leading cause of mortality in women.^\[[@R3]\]^ It is therefore a huge burden for both patients and society. BC is a multifactorial disease caused by complex inherited and environmental factors.^\[[@R4]\]^ One of the most common causes is genetic mutation. Numerous genetic alterations influence human breast carcinogenesis by affecting cell growth, proliferation, differentiation, apoptosis, and invasion.^\[[@R5]\]^ However, although BC has been extensively researched in recent years, and numerous biomarkers have proved to be effectual for the diagnosis and management of BC, it remains one of the leading causes of cancer death.^\[[@R3]\]^ Therefore, the mechanism underlying the development of BC is intricate, and further research is required to discover the genes involved in BC pathogenesis to develop novel therapeutic targets for treating the disease. Though Santpere et al described genes that change in DCIS and basal-like tumors with respect to normal breast,^\[[@R6]\]^ the dynamic change of co-expression network from normal breast tissue to ductal carcinoma in situ (DCIS), and subsequently to all subtypes of invasive breast cancer (IBC), are still unclear.

Recent developments in oligonucleotide microarray and sequencing technologies have enabled the rapid monitoring of gene expression in various tissues, and have provided an excellent tool and platform for cancer research.^\[[@R7],[@R8]\]^ Owing to the accurate determination of tumor phenotypes, expression-based classification offers insight into the molecular aspects of tumor progression, recurrence, and differentiation.^\[[@R9],[@R10]\]^ facilitating the discovery of new biomarkers. Traditional differentially expressed genes (DEGs) network analysis can be used to identify differentially expressed genes in cancer patients compared to normal people. However, such analysis conventionally treats thousands of genes independently, and ignores the high interconnection of the transcriptome. Moreover, it encompasses different expression profiles of thousands of genes driven by a wide range of factors, so it is difficult to determine which genes play a key role in the development of BC.

Scale-free networks differ significantly from random networks. The most notable characteristic of a scale-free network is the relative commonness of vertices with a degree that greatly exceeds the average. The highest-degree nodes are often called \"hubs", and are thought to serve specific purposes in their networks. WGCNA is based solely on a scale-free network that is used to determine the relationships between genes, thereby enabling the identification of modules (clusters) of highly correlated genes,^\[[@R11]\]^ and the hub gene in each module. Thus, WGCNA is ideal for the identification of gene modules and key genes that contribute to phenotypic traits. For example, Colin et al identified 11 gene co-expression clusters from large-scale BC data using WGCNA, and suggested that *UBE2S* indicates a poor prognosis for BC.^\[[@R12]\]^ Therefore, in the current study, we aimed to use the WGCNA algorithm to identify highly correlated gene modules that are associated with BC development, then detected the hub genes (network-centric genes), to uncover new biomarkers proved to be effectual for the diagnosis and treatment of breast cancer.

2. Materials and methods
========================

Statistical computations were performed using R statistical software (version 3.5) with related packages or our customized functions.

2.1. Microarray data
--------------------

The microarray gene expression profiles were downloaded from the GEO (www.ncbi.nlm.nih.gov/geo) database with accession numbers GSE15852 and GSE92697. A total of 112 samples were included in the dataset (42 IBC, 27 DCIS, and 43 normal breast samples). The 2 series have good consistency after adjusting the batch effects. Microarray annotation information (HG-U133A Annotations) was used to match a total of 22,283 microarray probes with the corresponding genes. Probes with more than one gene were eliminated, and the average values were calculated for those genes corresponding to more than one probe. Therefore, 12,709 unique genes representing the expression profiles were used for analysis. The data of this study are derived from gene databases, so ethical approval is not applicable.

2.2. Co-expression module detection
-----------------------------------

We initially used the flashClust tool in the R language to carry out cluster analysis of the samples with the appropriate threshold value to detect and remove the outliers. The gradient method was used to test the independence and the average degree of connectivity of the various modules with different power values (the power values ranged from 1 to 20). Once the appropriate power value had been determined when the degree of independence was 0.8, the module construction proceeded with the WGCNA algorithm. Modules were identified as gene sets with high topological overlap.^\[[@R13]\]^ The minimum number of genes was set at 30 to ensure high reliability. Subsequently, the information pertaining to the corresponding genes in each module was extracted.

2.3. Module and clinical trait association analysis
---------------------------------------------------

The WGCNA algorithm utilizes module eigengenes (MEs) to assess the potential correlation of gene modules with clinical traits. In the present study, the MEs were defined as the first principal components calculated using principal component analysis, which summarizes the expression patterns of the module genes into a single characteristic expression profile. The expression patterns of modules associated with the kinds of samples were then calculated using gene significance (GS) and module significance (MS). The GS of a gene was defined as the correlation coefficients for different kinds of samples, whereas MS was indexed as the average GS for all the genes in the module.

2.4. Functional annotation of module
------------------------------------

Functional annotation of the modules was performed on the basis of analysis of their gene composition. Gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were performed to explore the biological functions of selected genes in the modules that had high correlation with BC development using the DAVID bioinformatics tool (version 6.7, <https://david.nciferf.gov/>). A *P* value ≤ .05 after correction was used as the threshold. The top 4 records of the 3 GO sub-vocabularies (\"cellular component", CC; \"biological process", BP; \"molecular function", MF) and KEGG pathways were extracted.

2.5. Association analysis and hub genes
---------------------------------------

The kME --- which is the distance from the expression profile of a gene to that of the module eigengene --- was determined as the Pearson correlation coefficient between each individual gene and the ME. Thus, kME quantifies how close a gene is to a module, that is, it measures the module membership of a gene. The hub genes are those genes with high network connectivity in a particular group. Furthermore, the hub genes of modules are also highly associated with the corresponding clinical traits of the modules. Thus, genes with the highest kME and highest GS in the module were informally referred to as intramodular hub genes.

2.6. Validation the hub genes by Oncomine database
--------------------------------------------------

Oncomine (<https://www.oncomine.org/resource/login.html>) is a cancer microarray database that allows researchers to mine web-based data on genome-wide expression in various types of human cancers and the corresponding normal tissues.^\[[@R14],[@R15]\]^ The database is constantly updated to provide users with the most advanced data and tools available. Therefore, we used Oncomine because it is powerful tool that provides a better understanding of the molecular mechanisms underlying BC development, and the validation of new targets and biomarkers.

3. Results
==========

3.1. Identification of gene co-expression modules
-------------------------------------------------

The dataset and samples were described in the methods. WGCNA is memory consumption. Therefore, a weighted gene co-expression network was constructed from the 4236 most varied genes (the top 1/3 of the 12,709 genes) which included almost all the differentially expressed genes among groups. The flashClust tools package was used to perform the cluster analysis, and 4 outlier samples were subsequently detected and removed (Fig. [1](#F1){ref-type="fig"}A). The most critical parameter in WGCNA analysis is the power value, which mainly affects the independence and the average degree of connectivity of the co-expression modules. Figure [1](#F1){ref-type="fig"}B shows that when the power value was equal to 5, our data predicted a gene co-expression network that exhibited scale-free topology with inherent modular features.

![(A) Cluster tree of normal, DCIS and IBC samples. The first color-band underneath the tree indicates which arrays appear to be outlying (colored red). The other color bands color-code the sample traits. The BC development in Figure 1 means the dynamic changes of gene expression from normal to DCIS and then to IBC. (B) Analysis of network topology for various soft-thresholding powers. BC = breast cancer, DCIS = ductal carcinoma in situ, IBC = invasive breast cancer.](medi-98-e14345-g001){#F1}

We then calculated the topological overlap measure (TOM) for each gene pair. Hierarchical clustering based on TOM dissimilarity measure (1-TOM) stability revealed 17 modules (Fig. [2](#F2){ref-type="fig"}A). Each module contained a group of coordinately expressed genes with high TOM, and was potentially involved in shared biological processes. To distinguish the modules individually, each module was assigned a unique color, and the corresponding numbers of genes in these modules are shown in Figure [2](#F2){ref-type="fig"}B. The background color is grey and represents the 463 genes not assigned to any module. The entire gene expression network is representation in the heatmap plot shown in Figure [3](#F3){ref-type="fig"}A and the multi-dimensional scaling plot shown in Figure [3](#F3){ref-type="fig"}B.

![(A) Hierarchical cluster tree of the 4236 genes. The first band shows the assigned module colors and the second color band represents the gene significance measure: "red" indicates a high positive correlation with BC development. (B) The number of genes in the 17 modules. BC = breast cancer.](medi-98-e14345-g002){#F2}

![(A) Heatmap plot representing the gene network. The heatmap depicts the topological overlap matrix among all genes in the analysis. (B) Multi-dimensional scaling (MDS) plots representing the entire gene expression network. Each gene is represented by a dot, where the color of the dot corresponds to the gene module to which that gene belongs.](medi-98-e14345-g003){#F3}

3.2. Association of modules with clinical traits
------------------------------------------------

Interaction analysis of co-expression modules associated with tumor characteristics identified correlation between module eigengenes (MEs) and tumor characteristics (Fig. [4](#F4){ref-type="fig"}A). The eigengene of the tan module (88 genes) had significant correlation with BC development (cor = .71, *P* = 8 × 10^−18^), whereas the eigengene of the brown module (519 genes) had the highest negative correlation (cor = −.6, *P* = 4 × 10^−11^). Furthermore, the eigengenes of greenyellow (94 genes) and turquoise (920 genes) modules were also highly correlated with BC development (cor = .47, *P* = 4 × 10^−7^ and cor = .44, *P* = 2 × 10^−6^, respectively). Figure [4](#F4){ref-type="fig"}B shows a hierarchical clustering dendrogram of the eigengenes (the top panel) as well as eigengene adjacency network (the bottom panel), which also confirmed that the eigengene of the tan module is the highest one that correlated with BC development. The dynamic changes of MS from normal tissue to DCIS, and then to IBC, were shown in Figure [5](#F5){ref-type="fig"}. Tan module shows the highest MS in IBC patients and the lowest in normal patient. However, the brown module exhibited exactly opposite results.

![(A) Pearson correlation coefficient matrix among module eigengenes (MEs), and breast cancer characteristics. Each cell reports the correlation (and *P*-value) between module eigengenes (rows) and traits (columns). (B) Eigengene network representing the relationships among the modules and the sample traits. BC = breast cancer, MEs = module eigengenes.](medi-98-e14345-g004){#F4}

![GS Score for all modules corresponding to normal, DCIS, IBC samples and BC development. BC = breast cancer, DCIS = ductal carcinoma in situ, GS = gene significance, IBC = invasive breast cancer.](medi-98-e14345-g005){#F5}

3.3. Functional enrichment analysis of genes in modules of interest
-------------------------------------------------------------------

Because the tan, greenyellow, turquoise, and brown modules were all highly correlated with BC development, we conducted GO and KEGG enrichment analysis to obtain further biological insight into each module. For the tan module, which had strong positive correlation with BC development, the genes were mainly enriched in GO: 0016477 (cell migration). For the brown module, which had strong negative correlation with BC development, the genes were mainly enriched in GO: 0007155 (cell adhesion). Categories related to GO: 0070062 (the cell cycle) and GO: 0070062 (cell--cell adhesion) were significantly over-represented in the remaining 2 modules, namely the greenyellow and turquoise co-expression modules, respectively. The complete information relating to the significant biological GO terms and KEGG pathways for these 4 modules is shown in Figure [6](#F6){ref-type="fig"}.

![GO analysis and KEGG pathway enrichment analysis for genes in tan (A), brown (B), turquoise (C), and greenyellow (D) modules. GO = gene ontology, KEGG = Kyoto Encyclopedia of Genes and Genomes.](medi-98-e14345-g006){#F6}

3.4. Module visualization and hub genes
---------------------------------------

First, we created a scatterplot of GS of BC development versus Module Membership in the 17 modules (Fig. [7](#F7){ref-type="fig"}). We found that the tan, greenyellow, turquoise, and brown modules all contained genes with the highest GS for BC development and highest intramodular connectivity, which suggests that the intramodular hub genes of these modules were highly correlated with BC development.

![Scatterplot of Gene Significance of BC development versus intramodular k (Module Membership) in the 17 modules. BC = Breast cancer, GS = gene significance.](medi-98-e14345-g007){#F7}

Then we used Cytoscape software to visualize the network of targeted modules and the intra-modular connectivity, which was calculated by WGCNA (Fig. [8](#F8){ref-type="fig"}). The hub genes in the tan module included *SLC38A1*, the *KRT* family (*KRT8*, *KRT18*, and *KRT19*), *EPCAM*, *HMGN1*, etc. With regard to the remaining 3 modules, the most significant hub genes were *BUB1B*, *MORF4L2*, and *TNS1* in the greenyellow, turquoise, and brown modules, respectively.

![Visualization of weighted gene co-expression network analysis (WGCNA) network connections of the intramodular hub genes and the top 50 genes in tan (A), green-yellow (B), turquoise (C) and brown (D) module.](medi-98-e14345-g008){#F8}

3.5. Expression of hub genes in breast cancer and normal tissues
----------------------------------------------------------------

We evaluated the transcription levels of the hub genes in our 4 targeted modules in BC and normal tissues using the Oncomine database. The Curtis breast dataset revealed that the *EPCAM*, *KRT8*, *KRT19*, *KPNA2*, *MELK*, and *ECT2* expression levels were significantly higher in BC than in normal tissues, with fold changes larger than 2. *SLC38A1*, *HMGN1*, *CD9*, *CBX3*, *ACTR3*, and *MORF4L2* expression levels were moderately higher in BC than in normal tissues, with fold changes between 1.4 and 2.0. There were no differences in the expression levels of *BUB1B*, *KRT18*, or *MYO6* between BC tissue and normal tissue. However, the expression levels of *TNS1*, *ADH1B*, *PNN*, *ITIH5*, and *LPL* were markedly lower in the BC tissue than in the normal tissue (Fig. [9](#F9){ref-type="fig"}).

![Hub genes expression levels in breast cancer and normal tissues using the Curtis breast dataset. The *P* values were calculated using a log-rank test, and *P* \< .05 was regarded as statistically significant.](medi-98-e14345-g009){#F9}

4. Discussion
=============

To the best of our knowledge, this is the first report on the use of WGCNA analysis to dynamically study co-expression genes in normal breast tissues, DCIS tissues, and IBC tissues, and to explore related modules and hub genes. We conclude that the tan module, which focused on the cell migration pathway, had the highest correlation with BC development. The functions of the other 3 modules, which were also correlated with BC development, focused on the cell cycle, cell division, and cell adhesion. Several hub genes derived from these modules that are associated with BC were uncovered; some have been reported to exhibit high tumorigenicity. However, some newly discovered genes may become potential makers for the diagnosis and treatment of BC. Our long-term goals are to provide insight into the mechanisms underlying BC development, and to help identify patients who are likely to develop BC, and who would benefit from alternative clinical diagnosis and therapy.

Cloning and migration are the 2 basic characteristics of cancer cells. The function of the tan module, which was identified as the most significant module associated with BC development, concerned the cell migration pathway and the formation of the anatomical structures involved in morphogenesis. Therefore, this upregulation of the co-expressed genes plays a central role in increasing the migration of epithelial cells and promoting structure formation in BC.

Among the hub genes in the tan module, *EPCAM* is considered the most frequently and intensely studied tumor-associated antigen gene because it is overexpressed in most epithelium-derived tumors, including colorectal,^\[[@R16]\]^ breast,^\[[@R17]\]^ pancreatic,^\[[@R18]\]^ and liver.^\[[@R19]\]^ Furthermore, *EPCAM* is also regarded as a prognostic tumor biomarker for cancer diagnosis, prognosis, and therapy.^\[[@R20]\]^ However, the mechanism by which *EPCAM* is associated with cancer formation has remained elusive. Other important hub genes in this module were mainly located in the keratins (KRTs) family, demonstrating that KRTs play a critical role in the development of BC. *KRT8*, a type II basic intermediate filament protein, is expressed in many simple epithelial cells.^\[[@R21]\]^*KRT8* is also positively expressed in head-and-neck squamous cell carcinomas and metastases.^\[[@R22]\]^ As for the association between *KRT8* and BC, only one study reported that KRT8 combined with urokinase-type plasminogen activator, plasminogen, and fibronectin constitutes a signaling platform that can modulate breast tumor cell adhesion and invasiveness.^\[[@R23]\]^*KRT19* expression is also proved to be associated with poor tumor differentiation and aggressive tumor behavior in hepatocellular carcinoma.^\[[@R24]\]^ However, it can be seen that there are few reports on the functions of the KRT family associated with BC formation in the literature. Therefore, the 2 most important hub genes (*KRT8* and *KRT19*) in this module are potential new markers for the diagnosis and treatment of BC.

Gene functions in the greenyellow module concerned cell division, and the cell cycle pathway. Cancer basically results from uncontrolled cell division. The formation and progression of cancer is usually linked to a series of changes in the activity of cell cycle regulators. The hub genes in this module included *KPNA2*, *MELK*, and *ECT2*. A large number of reports have now confirmed that *MELK* can regulate cell proliferation and apoptosis, and promote cancer cell metastasis.^\[[@R25]\]^ However, there has been little research on *KPNA2*. A few studies have shown that the expression of *KPNA2* is associated with aggressive behaviors such as higher tumor grade and positive lymph node,^\[[@R26],[@R27]\]^ and with poor outcomes in BC.^\[[@R28]\]^*ECT2*, which is considered a major oncogene involved in the onset or progression of human cancers, induces the malignant transformation of both epithelial cells and fibroblasts, indicating its vital role in the malignant transformation of cells.^\[[@R29]\]^ Therefore, *ECT2* is likely to play a key role in the interaction between BC epithelial cell and the tumor microenvironment.

The function of the genes in the turquoise module concerned poly(A) RNA binding, protein processing in the endoplasmic reticulum, RNA transport, and metabolic pathways, which implies that the genes in this module inhibit transcription and regulate the metabolism of tumor cells. The functions of the genes in the brown module concerned the regulation of the PI3K-Akt signaling pathway, the transcription of RNA polymerase II promoter, and signal transduction. The PI3K-Akt signaling pathway plays an essential role in several cell processes including cell proliferation, growth, survival, angiogenesis, and malignancies.^\[[@R30]\]^*TNS1*, *ADH1B*, and *LPL*, which are markers of unfavorable prognoses in many cancers, were markedly downregulated in BC, but the underlying mechanisms require further investigation.

Though the majority of hub genes highlighted in this study have been reported, all the studies just discussed the correlation between the expression of a single gene, such as *KRT8*, *KRT19*, *KPNA2*, and *ECT2* et al and the prognosis of breast cancer. However, in our study, we focus on the genes that play critical roles in the occurrence and development of breast cancer. Besides, WGCNA analysis was used to detect the correlation of these hub genes, which will help us understand the interaction of these genes as well as the mechanism that associated with breast cancer development.

5. Conclusion
=============

In summary, our study used a systems biology-based WGCNA approach to demonstrate that 4 modules were correlated with IBC development. The functions of these modules were concentrated in migration, cell division, cell proliferation, and cell adhesion. Hub genes such as *EPCAM* and *MELK* are highly correlated with breast cancer development. However, *KRT8*, *KRT19*, *KPNA2*, and *ECT2* may also have potential as diagnostic and prognostic biomarkers of IBC. Our results require further verification.
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